Abstract:<h3 class="Heading"> <em><strong class="EmphasisTypeBoldItalic">BACKROUND:</strong></em> </h3><p class="Para">CRISPR/Cpf1 is a class II, type V RNA-guided endonuclease that is distinct from the type II CRISPR/Cas9 nuclease, widely used for genome editing. Cpf1 is a smaller and simpler endonuclease than Cas9, overcoming some limitations of the CRISPR/Cas9 system. The applications of CRISPR to rodent embryos for the production of knock-out (KO) mice have been achieved mainly by microinjection, which requires heavily-equipped instruments with skillful hands. Here, we evaluated the genome editing efficiency between Cpf1/mRNA and Cpf1/ribonuclear protein (RNP) in mouse embryos, and established an easy, fast, and technically less demanding method to produce KO mice using electroporation of the Cfp1/RNP system.</p><h3 class="Heading"> <em><strong class="EmphasisTypeBoldItalic">METHODS:</strong></em> </h3><p class="Para">The efficiency of electroporation-based delivery of AsCpf1/mRNA and AsCpf1/RNP to target exon 3 of leukemia inhibitory factor (<em class="EmphasisTypeItalic">Lif</em>) into mouse zygotes was evaluated. Embryos that developed to the two-cell stage after zygote electroporation were transferred into the oviducts of surrogate mothers to produce AsCpf1-mediated LIF KO mice. The genome editing efficiency of blastocysts and pups was tested using the T7E1 assay and/or DNA sequencing. Congenital abnormalities and reproductive phenotypes in LIF KO mice produced by electroporation with AsCpf1/RNP were examined.</p><h3 class="Heading"> <em><strong class="EmphasisTypeBoldItalic">RESULTS:</strong></em> </h3><p class="Para">Survival and two-cell development of electroporated zygotes were comparable between the AsCpf1/mRNA and AsCpf1/RNP groups, whereas genome editing efficiency was relatively higher in the AsCpf1/RNP group (13.3% vs 18.1% at blastocyst and 33.3% vs 45.5% at offspring), respectively. Two mouse lines with a frameshift mutation in exon 3 of the <em class="EmphasisTypeItalic">Lif</em> gene were established from the AsCpf1/RNP group. All congenital abnormalities of LIF KO mice produced by AsCpf1/RNP electroporation were observed. AsCpf1-mediated LIF KO mice showed postnatal growth retardation and implantation failure, both of which are major phenotypes of LIF KO mice generated by conventional gene targeting.</p><h3 class="Heading"> <em><strong class="EmphasisTypeBoldItalic">CONCLUSION:</strong></em> </h3><p class="Para">Electroporation of AsCpf1/RNP at the zygote stage is an efficient genome editing method to produce KO mice.</p>

Electroporation-mediated genome editing in vitrified/warmed mouse zygotes created by IVF via ultra-superovulation

Efficient Genome Editing of Mice by CRISPR Electroporation of Zygotes

An optimized electroporation approach for efficient CRISPR/Cas9 genome editing in murine zygotes

Genome editing using type I-E CRISPR-Cas3 in mice and rat zygotes

Efficient genome editing of two-cell mouse embryos via modified CRISPR/Cas electroporation

Production of knockout mice by DNA microinjection of various CRISPR/Cas9 vectors into freeze-thawed fertilized oocytes

Ultra-superovulation for the CRISPR-Cas9-mediated production of gene-knockout, single-amino-acid-substituted, and floxed mice

Simplified pipelines for genetic engineering of mammalian embryos by CRISPR-Cas9 electroporation†

Electroporation-mediated genome editing in vitrified/warmed porcine zygotes obtained in vitro

Rapid and efficient production of genome-edited animals by electroporation into oocytes injected with frozen or freeze-dried sperm

Introducing gene deletions by mouse zygote electroporation of Cas12a/Cpf1

Electroporation and genetic supply of Cas9 increase the generation efficiency of CRISPR/Cas9 knock-in alleles in C57BL/6J mouse zygotes

Efficient and Fast Generation of Relevant Disease Mouse Models by In Vitro and In Vivo Gene Editing of Zygotes

A non-inheritable maternal Cas9-based multiple-gene editing system in mice

i-GONAD: a robust method for in situ germline genome engineering using CRISPR nucleases

Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONAD

Generation of an Oocyte-Specific Cas9 Transgenic Mouse for Genome Editing.

Genetic Modification of Mice Using Prime Editing

Electroporation Delivery of Cas9 sgRNA Ribonucleoprotein-Mediated Genome Editing in Sheep IVF Zygotes

Electroporation of AsCpf1/RNP at the Zygote Stage is an Efficient Genome Editing Method to Generate Knock-Out Mice Deficient in Leukemia Inhibitory Factor

An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing